Open AccessThe Impact of Sirolimus on hepatitis C Recurrence after Liver Transplantation
Author(s) -
Sonal Asthana,
Christian Toso,
Glenda Meeberg,
David L. Bigam,
Andrew L. Mason,
AM James Shapiro,
Norman M. Kneteman
Publication year - 2011
Publication title -
canadian journal of gastroenterology
Language(s) - English
Resource type - Journals
eISSN - 1916-7237
pISSN - 0835-7900
DOI - 10.1155/2011/201019
Subject(s) - medicine , immunosuppression , liver transplantation , gastroenterology , hepatitis c , cirrhosis , hepatitis c virus , cohort , transplantation , incidence (geometry) , tacrolimus , retrospective cohort study , surgery , immunology , virus , physics , optics
While some immunosuppression strategies may accelerate hepatitis C virus (HCV) recurrence after liver transplantation (LT), the impact of sirolimus (SRL) is not known.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom